Tegoprazan: a novel, highly selective, and potent potassium-competitive acid blocker (P-CAB).

Few decades back, researchers have been paid attention to overcome limitations of PPIs, thus explored an innovative drug class "potassium-competitive acid blockers (P-CABs)" to achieve rapid, potent, and prolonged gastric acid inhibition. Tegoprazan is first self-developed P-CAB in China. Purpose: W...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Clinical Pharmacology Vol. 81; no. 8; pp. 1103 - 1118
Autores principales:	Wang, Wenlu, Yaseen, Hafiza Sidra, Li, Xiaoji, Ahmad, Muhammad Zia, Chen, Yaowu, Li, Guorong, Naveed, Muhammad, Zubair, Hafiz Muhammad, Bibi, Jannat
Formato:	pictorial review tables/charts Journal Article
Publicado:	Springer Nature Aug2025
Acceso en línea:	Ver este registro en EBSCOhost